ClinicalTrials.Veeva

Menu

Tunnel Access for Horizontal Alveolar Ridge Augmentation

U

University of Bari Aldo Moro

Status

Completed

Conditions

Bone Atrophy, Alveolar
Alveolar Bone Loss
Alveolar Bone Resorption
Bone Loss
Bone Resorption

Treatments

Procedure: Horizontal Ridge augmentation

Study type

Interventional

Funder types

Other

Identifiers

NCT06424223
Mini-invasiveRidgeAugmentation

Details and patient eligibility

About

Minimally invasive procedures with the tunnel technique have been suggested to decrease patient post-operative discomfort and morbidity in oral bone regeneration. In the ridge augmentation tunnel technique, crestal incision and the release of the connective tissue are avoided in order to enhance the blood supply of the flap. This approach preserves the blood circulation and does not damage the periosteum The purpose of this study is to evaluate the clinical outcome of a minimally invasive technique for maxillofacial horizontal bone augmentation .

Full description

Several techniques have been introduced to minimize the invasiveness involved in oral bone regeneration, to prevent the coronal advancement of the flap, which in turn reduces postoperative discomfort, swelling, complications, and mobility.

The tunnel technique involves making a vertical incision to access the bone defect and inserting the grafts. The significant benefit of this approach is that it may be closed without the need for periosteal incisions. Several tunnel techniques have been described in the literature using various biomaterials including bovine bone, synthetic bone, bovine bone block, allograft block bone, hidroxiapatite. This clinical study assesses the efficiency of a minimally invasive surgical technique for horizontal ridge augmentation using Biphasic Calcium Phosphate and Acellular Dermal Matrix.

This minimally invasive procedure aims to increase the horizontal volume of the edentulous ridge in both its bone component (through the use of Biphasic Calcium Phosphate) and its mucosal component (through the use of Acellular Dermal Matrix). Compared to other traditional techniques, this procedure, performed through a tunnel approach, would significantly reduce the invasiveness of the treatment.

Enrollment

5 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients had to be healthy according to System of the American Society of Anesthesiology (ASA) and aged 18 years or older

    • No general medical condition representing a contraindication to implant therapy
    • minimum 2 missing teeth in the maxilla or mandible from the canine to the second molar
    • No periodontal disease (periodontal probing depth <4 mm) or treated periodontitis
    • Good oral hygiene (full mouth plaque index<25%)
    • Adequate control of inflammation (full mouth bleeding on probing<25%)

Exclusion criteria

  • smoking of more than 15 cigarettes a day • untreated periodontal disease
  • pregnancy or breastfeeding at date of inclusion • acute infections
  • keratinized mucosal tissue less than 2 mm.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

5 participants in 1 patient group

Ridge augmentation
Experimental group
Treatment:
Procedure: Horizontal Ridge augmentation

Trial contacts and locations

1

Loading...

Central trial contact

Giuseppe D'Albis

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems